CANDEL THERAPEUTICS

At Candel Therapeutics, we are developing immunotherapies that induce immunogenic cell death in cancer cells at the site of injection, unmasking tumor neo-antigens within an activated microenvironment. This process leads to a systemic, durable immune response against the tumor, with the potential to change disease outcomes across a variety of indications... At Candel Therapeutics, our team is developing oncolytic viral immunotherapies that light up and empower the immune system to fight cancer... is made up of renowned drug developers, oncolytic viral immunotherapy experts, oncologists, immunologists and biotech business leaders. Candel is built on science, and our experienced team is helping translate its full promise to patients.

Primary location: Needham United States